Autoantibody to centromere (kinetochore) in scleroderma sera

Area of Science:

• Immunology
• Cell Biology
• Genetics

Background:

• Scleroderma is an autoimmune disease characterized by various nuclear autoantibodies.
• Nuclear autoantibodies exhibit distinct immunofluorescence staining patterns.
• Centromeric autoantibodies are a subset of these antibodies.

Purpose of the Study:

• To characterize autoantibodies found in scleroderma patient sera.
• To identify the specific nuclear antigen targeted by a particular autoantibody.
• To investigate the prevalence of this autoantibody in scleroderma subtypes.

Main Methods:

• Immunofluorescence staining of cell nuclei and chromosome spreads.
• Analysis of autoantibody reactivity with cellular components.
• Serological testing of patient samples.

Main Results:

• Sera from scleroderma patients revealed autoantibodies against nuclear antigens with diverse staining patterns.
• A specific autoantibody was identified that binds to the centromeric regions of chromosomes.
• This centromere-reactive autoantibody showed characteristic staining resembling kinetochores in chromosome spreads.
• The autoantibody recognized determinants in human, mouse, and Chinese hamster cells.
• High frequency of this autoantibody was observed in patients with the CREST (calcinosis/Raynaud's phenomenon/esophageal dysmotility/sclerodactyly/telangiectasia) variant of scleroderma.

Conclusions:

• Scleroderma is associated with autoantibodies targeting nuclear antigens, including centromeres.
• The centromere-specific autoantibody is a significant marker, particularly in the CREST subset of scleroderma.
• This autoantibody may target proteins or polypeptides associated with centromeric DNA.